Generate Biomedicines(GENB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GENB Generate Biomedicines

交易中 10-21 15:41:01 EDT

13.17

+0.27

+2.05%

最高13.21	最低12.80	成交量26.84万
今开13.04	昨收12.90	日振幅3.18%
总市值16.88亿	流通市值7.94亿	总股本1.28亿
成交额351.81万	换手率0.45%	流通股本6,029万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GENB","market":"US","secType":"STK","nameCN":"Generate Biomedicines","latestPrice":13.165,"timestamp":1792611660813,"preClose":12.9,"halted":0,"volume":268353,"delay":0,"changeRate":0.020542635658914635,"floatShares":60288200,"shares":128192484,"eps":-3.27625,"marketStatus":"交易中","change":0.265,"latestTime":"10-21 15:41:01 EDT","open":13.04,"high":13.21,"low":12.8,"amount":3518118.832473,"amplitude":0.031783,"askPrice":13.18,"askSize":745,"bidPrice":13.15,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-3.27625,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1792612800000},"marketStatusCode":2,"adr":0,"listingDate":1772168400000,"exchange":"NASDAQ","adjPreClose":12.9,"preHourTrading":{"tag":"盘前","latestPrice":13.1,"preClose":12.9,"latestTime":"09:27 EDT","volume":4904,"amount":64655.39036,"timestamp":1792589242513,"change":0.2,"changeRate":0.015504,"amplitude":0.045736},"postHourTrading":{"tag":"盘后","latestPrice":13,"preClose":12.9,"latestTime":"19:57 EDT","volume":12794,"amount":165224.7373,"timestamp":1792540635025,"change":0.1,"changeRate":0.007752,"amplitude":0.012403},"volumeRatio":0.270524,"impliedVol":0.8389,"impliedVolPercentile":0.3571},"requestUrl":"/m/hq/s/GENB/tweets","defaultTab":"tweets","newsList":[{"id":"1196527286","title":"Generate Biomedicines：现有现金、现金等价物及有价证券足以支撑运营计划至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1196527286","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1196527286?lang=zh_cn&edition=full","pubTime":"2026-08-06 19:13","pubTimestamp":1786014817,"startTime":"0","endTime":"0","summary":"Generate Biomedicines 宣布，公司当前持有的现金、现金等价物以及有价证券，已足够支持其现有运营计划，直至2028年上半年。这一资金储备状况，为公司未来的研发与业务拓展提供了坚实的财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GENB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176782309","title":"Generate Biomedicines预计现有资金可支持运营至2028年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1176782309","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1176782309?lang=zh_cn&edition=full","pubTime":"2026-05-07 18:21","pubTimestamp":1778149271,"startTime":"0","endTime":"0","summary":"Generate Biomedicines公司近日表示，其现有的现金、现金等价物及有价证券储备预计足以支撑公司日常运营持续至2028年上半年。这一资金规划为企业的长期发展战略提供了稳定的财务基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GENB"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.generatebiomedicines.com","stockEarnings":[{"period":"1week","weight":0.0526},{"period":"1month","weight":-0.2474},{"period":"3month","weight":-0.0719},{"period":"6month","weight":0.0031},{"period":"1year","weight":-0.1937},{"period":"ytd","weight":-0.1937}],"compareEarnings":[{"period":"1week","weight":-0.0115},{"period":"1month","weight":0.0097},{"period":"3month","weight":0.029},{"period":"6month","weight":0.0855},{"period":"1year","weight":0.1456},{"period":"ytd","weight":0.1278}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Generate Biomedicines, Inc.于2018年8月根据特拉华州法律成立。作为一家临床阶段的生成生物学公司，该公司首创了名为Generate Platform的人工智能驱动的生物技术平台，该平台将计算模型与可扩展的生物硬件相结合，以设计和开发新型治疗性蛋白质。其最先进的候选药物GB-0895是一种计算工程抗TSLP单克隆抗体，目前正处于严重哮喘的关键3期试验中。该平台的能力已通过在2026年将另外两个肿瘤候选药物推向1期试验而得到进一步证明。","exchange":"NASDAQ","name":"Generate Biomedicines","nameEN":"Generate Biomedicines"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Generate Biomedicines(GENB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Generate Biomedicines(GENB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Generate Biomedicines,GENB,Generate Biomedicines股票,Generate Biomedicines股票老虎,Generate Biomedicines股票老虎国际,Generate Biomedicines行情,Generate Biomedicines股票行情,Generate Biomedicines股价,Generate Biomedicines股市,Generate Biomedicines股票价格,Generate Biomedicines股票交易,Generate Biomedicines股票购买,Generate Biomedicines股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Generate Biomedicines(GENB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Generate Biomedicines(GENB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}